BTK and diffuse large B-cell lymphoma: Interestingly, we found that the KO of BTK sensitized both ABC and GCB DLBCL cells to platinum-based drugs, and cisplatin exposure resulted in a depletion of gRNAs targeting BTK, which is involved in BCR pathway signaling.